APA aipamena

Wells, A., Mallen, A., Bui, M., Reed, D., & Apte, S. (2019). NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report. Gynecol Oncol Rep.

Chicago Style aipamena

Wells, A.E., A.M Mallen, M.M Bui, D.R Reed, and S.M Apte. "NTRK-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case Report." Gynecol Oncol Rep 2019.

MLA aipamena

Wells, A.E., et al. "NTRK-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case Report." Gynecol Oncol Rep 2019.